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Background: Tetanus remains common in many low- and middle-
income countries (LMICs) yet the evidence base guiding management 
of this disease is extremely limited, particularly with respect to 
contemporary management options. Sharing knowledge about 
practice may facilitate improvement in outcomes elsewhere. 
Methods: We describe clinical interventions and outcomes of 180 
adult patients ≥16 years-old with tetanus enrolled in prospective 
observational studies at a specialist infectious diseases hospital in 
Southern Vietnam. Patients were treated according to a holistic 
management protocol encompassing wound-care, antitoxin, 
antibiotics, symptom control, airway management, nutrition and de-
escalation criteria. 
Results: Mortality rate in our cohort was 2.8%, with 90 (50%) patients 
requiring mechanical ventilation for a median 16 [IQR 12-24] days. 
Median [IQR] duration of ICU stay was 15 [8-23] days.  Autonomic 
nervous system dysfunction occurred in 45 (25%) patients. Hospital 
acquired infections occurred in 77 (43%) of patients. 
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Conclusion: We report favourable outcomes for patients with tetanus 
in a single centre LMIC ICU, treated according to a holistic protocol. 
Nevertheless, many patients required prolonged intensive care 
support and hospital acquired infections were common.
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Introduction
Tetanus is a vaccine-preventable disease that remains a common 
cause of acute critical illness in low-income and middle-income 
countries (LMICs)1. Signs and symptoms are due to the effects 
of tetanus toxin in the central nervous system and management 
is based on three key strategies: blocking further tetanus toxin 
release2, neutralising unbound toxin3, and alleviating effects of 
already-bound toxin; namely muscle spasms and autonomic 
nervous system dysfunction1,4,5. With access to critical care 
interventions such as mechanical ventilation and advanced 
physiological monitoring, muscle spasms and autonomic nervous 
system dysfunction (ANSD) can be more easily managed6–8. 
These interventions are now available in many LMIC intensive 
care units (ICUs); however, their availability is often not 
associated with improved outcomes9,10.
As almost all tetanus occurs in settings with limited capacity 
for clinical trials, the evidence base for tetanus management 
remains limited. There are few randomized clinical trials to 
support common management strategies and, in the absence 
of high-quality evidence, observational studies and case series 
become the key elements in guiding treatment. The Hospital 
for Tropical Diseases, Ho Chi Minh City, has been a tertiary 
referral centre for tetanus for over 30 years and has developed 
and implemented a specific holistic management protocol for 
patients with tetanus. The ICU continues to admit several 
hundred adult patients with tetanus every year and reports 
outcomes comparable with those from high income settings7,11.
The overall aim of this paper is to pragmatically describe the 
intensive care management of adult tetanus in a LMIC setting 




The Hospital for Tropical Diseases (HTD), Ho Chi Minh 
City is a tertiary referral centre for infectious diseases serving 
Southern Vietnam. Previously the hospital housed a special 
tetanus ICU but whilst this no longer exists, the hospital’s adult 
ICU continues to receive 250-350 adult patients with tetanus 
annually. The principles of tetanus management described 
above have been incorporated into a specific treatment protocol 
(Figure 1), which has been applied consistently to all patients 
over a 10 year period12. In addition to pharmacological 
interventions, the protocol includes directions for airway man-
agement, nutrition and nursing observations. It also includes 
criteria for de-escalation and discharge from hospital.
Participants and data collection
Data on management and outcome of patients treated with this 
protocol were collected from prospective observational studies 
of two cohorts of patients ≥16 years old admitted to the hospi-
tal’s ICU with a diagnosis of generalized tetanus; the first from 
August 2016 - March 2017 and the second from January - July 
2018. For patients enrolled between August 2016 and March 
2017, additional exclusion criteria were: (i) not speaking 
Vietnamese, (ii) not being able to walk before admission.
Baseline and clinical variables including patient demographic 
details, tetanus severity indicators and management interventions 
and complications were collected prospectively on all enrolled 
subjects. Enrolled patients were followed daily until hospital dis-
charge. Previously described definitions were applied for hospi-
tal acquired infections13. Autonomic nervous system dysfunction 
(ANSD) was defined as at least three of: heart rate >100 beats 
per minute (bpm), systolic blood pressure >140 mmHg, mean 
arterial pressure < 60 mmHg, pyrexia > 38°C, and fluctuating 
blood pressure. All features should be present within one day 
with no other apparent cause14. Sensitivity evaluation of mortality 
rates within this study was performed by comparing with overall 
hospital database for outcomes of all patients with tetanus 
(ICD10 code A35) during the period 2016- 2018.
Statistical analysis
Descriptive statistics were used to describe the sample with the 
median and interquartile range (IQR) for continuous data, and 
count and percentage for categorical data. Due to small num-
bers of those who died, no comparative statistics have been 
performed. All analyses were carried out in Stata (StataCorp) 
version 16. Missing data are included and described in tables.
Ethics statement
This study was approved by the London School of Hygiene and 
Tropical Medicine (LSHTM) ethics committee, the Oxford 
Tropical Medicine Ethics Committee (OxTREC) and the local 
HTD ethics committee (Refs 16904, 596-16, 816 QD-BVBND, 
38-17, 494/ QD – SYT respectively.) All participants gave written 
informed consent to participate before enrolment.
Results
In total, 180 patients with generalised tetanus admitted to the 
ICU at HTD between August 2016 and July 2018 were included 
in this study. Out of a total 160 adult patients with tetanus 
admitted to the ICU, 80 patients were enrolled during the first 
period. For the second period, 100 patients were included out of 
a total of 120 admissions. Reasons for lower enrolment of the 
first cohort were largely pragmatic due to lack of availability of 
study staff and more stringent enrolment criteria. The median 
[IQR] age of the patients was 51.0 [40.8-61.5]. The youngest 
age was 17 and the oldest 98 years old. Of 180 patients, 73 
(40.6%) had at least one comorbidity and 143/180 (79.4%) 
were male. Median Tetanus Severity Score on admission was 
1.5 [IQR -3 – 5]15. Severe tetanus, defined as Ablett grade 3 or 4 
on hospital admission (i.e. spasms interfering with respiration 
with/without autonomic nervous system dysfunction), was 
diagnosed in 28 patients (16%), but an additional 66 (37%) 
progressed to severe disease during hospitalization. 
A summary of the management and complications of the 
patients during ICU admission are described in Table 1 and 
Table 2.
Description of the cases who died
Of the 5/180 (2.8%) patients that died, the median age was 
79 years [IQR 84-81], compared with 50 years [IQR 40-61] for 
the 175/180 (97.2%) patients who survived; 5/5 (100%) were 
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Figure 1. Summary of Tetanus Treatment Protocol Hospital for Tropical Diseases, Ho Chi Minh City.
male and 4/5 (80%) had comorbidities. On admission, amongst 
those who died, all 5/5 (100%) had difficulty breathing (noted 
by admitting doctors) compared to 32/175 (18.3%) for those 
who survived. The median SpO
2
 was 94% [IQR 94-97] 
compared with 97% [IQR 95-98] for those who survived and 
the median white blood cell (WBC) count was 16.8 [14.9-23.9] 
× 109/L compared with 9.8 [7.4-11.8] × 109/L for those who 
survived. Throughout ICU admission, amongst those who 
died, all 5/5 (100%) required mechanical ventilation. Two out of 
five (40%) patients that died developed ANSD, compared with 
43/175 (24.6%) in those who survived.
Three deaths were caused by cardiogenic shock (occurring at 
days 2, 12 and 15 of ICU admission), one death was due to sep-
tic shock secondary to ventilator associated pneumonia (occurring 
at day 5 of ICU admission) and one was due to ischaemic bowel 
and perforation (occurring at day 28 of ICU admission). Review 
of hospital records showed that in total, during the three years 
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Table 1. Description of intensive care unit management of enrolled tetanus 
patients.
Parameter Median [IQR] or Count (%)
Interventions 
Tracheostomy required 94 (52.2%)
Duration tracheostomy (days) (n=94) 18.5 [15-27]
Mechanical ventilation required 90 (50%)
Duration mechanical ventilation (days) (n=90) 16.0 [12-24]
Pharmaceutical agents required 
Duration diazepam required (days) (n=174) 14 [11-20]
Total dose diazepam (mg) (n=174) 585 [295-1352.5]
Maximum dose in 24 hours diazepam IV (mg) (n=97) 80 [20-120]
Maximum dose in 24 hours diazepam oral (mg) (n=170) 60 [45-120]
Maximum dose in 24 hours diazepam any route (mg) (n=173) 120 [60-120]
Duration midazolam required (days) (n=109) 10 [3-16]
Total dose midazolam during hospitalization (mg) (n=109) 996 [240-1905]
Maximum dose in 24 hours midazolam (mg) (n=109) 120 [92-168]
Total dose benzodiazepine during hospitalization (mg) 1627.5 [862.5-2526.2]
Maximum dose in 24 hours benzodiazepine (mg) 120 [120-160]
Duration magnesium sulphate (days) (n=50) 5 [3-8]
Total dose magnesium sulphate during hospitalization (g) 
(n=50) 203 [81-336]
Duration pipecuronium (days) (n=78) 13 [9-17]
Total dose pipecuronium during hospitalization (mg) (n=78) 410.3 [226.3-558.3]
2016- 2018, 917 adults were admitted with tetanus with an 
overall case fatality rate of 4% (including palliative discharges).
Discussion
We describe clinical features and outcomes of a large cohort 
of patients with tetanus managed at a specialist tetanus centre. 
Patients were managed in accordance with a standardized 
protocol by a team of doctors and nurses with significant 
experience in tetanus management7.
The case fatality rate in this study is 2.8%. This is, to our 
knowledge, the lowest reported mortality rate for a large series 
of tetanus patients worldwide12, and contrasts with rates reported 
from many other LMICs10,16. Whilst it is possible that selection 
bias has influenced our results, our figures are similar to official 
hospital records over the study period as well as an observational 
study enrolling patients with severe tetanus from our centre and 
one other major centre in Vietnam between 2013 and 201517. 
Comparison with contemporary data from other countries is more 
difficult due to limited reporting of established tetanus severity 
scores or known prognostic features. Nevertheless, the age of 
patients in our study (one of the strongest predictors of out-
come) is similar to, or even older than, those reported in other 
centres with worse outcomes10,18,19. Similarly, our ventilation rate 
was 50% but rates between 50% and 75% elsewhere have been 
associated with mortality rates of 30–35%10,19,20.
We believe that the favourable outcomes at our centre result 
from two major factors: a clear evidence-based management 
protocol and care by a highly specialized team with enormous 
experience in tetanus. Throughout the world, protocolized 
medical care is encouraged as a means of improving patient 
outcomes. Ideally, protocols are based on best evidence and can 
be regularly updated. However, this is not the case for many of 
the elements of our protocol due to the lack of high-quality 
contemporary evidence for tetanus management. Nevertheless, 
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Table 2. Complications and outcomes of enrolled patients.
Parameter Median [IQR] or 
Count (%)
Severity score 











Autonomic nervous system dysfunction 45 (25%)
Ventilator associated pneumonia 57 (31.7%)
Bacteraemia 19 (10.6%)
Urinary tract infection 39 (21.7%)
Any hospital acquired infection 77 (42.8%)
Pressure ulcer 18 (10%)
Duration of admission 
Length of intensive care unit stay (days) 15.0 [8.0-23.0]
Length of hospital stay (days) 25 [19.0-34.0]
Outcome 
Died in hospital** 5 (2.8%)
* Ablett score: Grade 1 is mild tetanus with no spasms, Grade 2 mild 
spasms not compromising breathing, Grade 3 is severe tetanus with 
spasms compromising breathing. Ablett Grade 4 is as Grade 3 but with 
additional signs of autonomic nervous system dysfunction21.
** Includes those taken home, expected to die.
the outcomes in our patients to some extent supports their 
continued use. A limitation of our work is that protocol adher-
ence itself was not specifically measured. Personal experience 
and treatment intervention data reported herein indicate that 
adherence was high; however, we have not specifically examined 
compliance with individual components of the protocol.
Our hospital is a tertiary infectious disease centre and receives 
patients with tetanus from Southern Vietnam. A highly developed 
referral system and limited staff turnover within the ICU means 
that experience in management of tetanus can be more read-
ily easily developed and preserved. Tetanus is a disease where 
progression continues to occur after hospitalization. Experienced 
staff may therefore be better able to anticipate complications, 
and so arrange care and interventions more appropriately. They 
may also be able to pass on subtle elements of care not out-
lined in our protocol – for example exactly when to intervene 
with spasms or how to balance risk of pressure area necrosis 
and spasm provocation when turning a patient. Finally, as a 
tertiary infectious disease centre there may be further factors 
that particularly benefited outcomes, such as more careful pre-
vention or management of hospital acquired infections which are 
particularly frequent in severe tetanus.
Sharing these forms of tacit knowledge is a challenge for health 
systems across the world but is most likely to benefit lower 
resourced settings with less access to specialised training and 
referral. The current expansion of digital technologies may 
offer possible solutions. For example, newer technologies in the 
form of telemedicine or even AI-enabled risk stratification 
may facilitate dissemination of less explicit knowledge or even 
simplify analysis of these complex processes.
Conclusions
We report management and outcome features in a large 
contemporary cohort of patients with tetanus treated according 
to a standardized protocol. Survival rates of these patients are 
high compared to other reported case series. Nevertheless, 
other outcomes such as duration of hospitalization and mechani-
cal ventilation requirements indicate that tetanus remains a 
significant burden on healthcare services. Therapies that can 
reduce these continue to be needed.
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